Skip to main content

Health condition

PSC deep dive

Primary sclerosing cholangitis (PSC) is a progressive inflammatory scarring of the bile ducts, closely linked with inflammatory bowel disease; there is no proven disease-modifying drug yet, so expert surveillance and timely transplant referral define good care.

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against current NHS and UK specialist society guidance at the time of review.

  • 03

    Current for 2026

    Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.

Key points

What matters most, at a glance.

The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.

  • Often diagnosed from persistently abnormal liver tests in someone with ulcerative colitis; itching, fatigue and cholangitis episodes come later

  • MRCP showing multifocal strictures and beading of the ducts makes the diagnosis - biopsy is needed only in suspected small-duct disease or overlap

  • Everyone with PSC should have colonoscopy at diagnosis, and annual surveillance colonoscopy if IBD is present, because bowel cancer risk is amplified

  • Bile duct cancer is the most feared complication; annual imaging with MRCP/ultrasound and a low threshold for investigating new strictures are standard

  • Fever with rigors and jaundice signals bacterial cholangitis - seek emergency care

  • Liver transplantation offers excellent outcomes and PSC is a leading indication in the UK

Understanding it

About PSC deep dive, and what to do next.

PSC scars ducts inside and outside the liver into a beaded, strictured tree, with bile stasis driving further injury. Its biology remains stubbornly unsolved - gut-liver immune traffic in genetically susceptible people is the leading model, fitting its intimate link with colitis - and drugs that help bile chemistry have not yet been proven to change its course.

What demonstrably changes outcomes is organised care: structured cancer surveillance across bile duct, gallbladder and colon; prompt endoscopic therapy of dominant strictures with sampling to exclude malignancy; bone health and fat-soluble vitamin attention; and transplant assessment before complications spiral. Patient organisations such as PSC Support are a valuable ally. Most people start with their GP, who can refer to a consultant hepatologist with a specialist interest in PSC. In many parts of the UK, routine NHS referrals for this kind of problem currently take 20-45+ weeks, whereas an initial private consultation is typically available within around two weeks.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any emergency symptoms described above.

Frequently asked

Common questions about PSC deep dive.

Quick, plain-English answers to what people ask us most.

  • What is primary sclerosing cholangitis (PSC)?

    PSC is a chronic condition causing inflammation and progressive scarring of the bile ducts, both within and outside the liver, strongly associated with inflammatory bowel disease, particularly ulcerative colitis.

  • What causes PSC?

    The exact cause isn't fully understood, but it's thought to involve an abnormal immune response, with genetic susceptibility and its strong link with inflammatory bowel disease suggesting a shared underlying mechanism.

  • What are the symptoms?

    Fatigue and itching are common early symptoms, sometimes with intermittent jaundice or bile duct infection episodes causing fever and abdominal pain; many people have few symptoms in earlier stages.

  • Is PSC dangerous?

    Yes, it's a serious, progressive condition that can lead to cirrhosis over time and carries an increased risk of bile duct cancer, making regular specialist monitoring important.

  • Can PSC be treated?

    There's no medication proven to halt PSC progression itself, so treatment focuses on managing symptoms, treating complications, and regular cancer surveillance, with liver transplantation an option for advanced disease.

  • How is PSC diagnosed?

    Specific imaging of the bile ducts (usually MRCP), combined with blood tests and sometimes a liver biopsy, establishes the diagnosis, alongside screening for associated inflammatory bowel disease.

  • How is PSC monitored over time?

    Regular blood tests, imaging surveillance for bile duct changes and cancer risk, and monitoring for inflammatory bowel disease are all important parts of ongoing PSC care.

  • PSC vs primary biliary cholangitis — what's the difference?

    PSC affects larger bile ducts inside and outside the liver and is strongly linked with inflammatory bowel disease, while primary biliary cholangitis specifically affects small bile ducts within the liver and is more common in women.

  • Does PSC increase cancer risk?

    Yes, PSC carries an increased risk of bile duct cancer and, for those with associated inflammatory bowel disease, colorectal cancer, making regular surveillance an important part of ongoing care.

  • When should I see a specialist, and how quickly can I be seen privately?

    See a hepatologist for unexplained fatigue, itching, or abnormal liver blood tests, particularly with known inflammatory bowel disease. Private specialist assessment is typically available within about two weeks, faster than standard NHS referral waiting times.